SCHEMBL8609649

SCHEMBL8609649

O=C(O)[CH]CCCCC(=O)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.68
▸ L3MBTL1 Q9Y468 2/20 0.68
▸ MAPT P10636 2/20 0.68
▸ LMNA P02545 1/20 0.68
▸ HDAC1 Q13547 8/20 0.61
▸ HDAC8 Q9BY41 6/20 0.61
▸ HDAC3 O15379 3/20 0.61
▸ HDAC2 Q92769 3/20 0.61
▸ HDAC4 P56524 2/20 0.61
▸ HDAC7 Q8WUI4 2/20 0.61
▸ HDAC10 Q969S8 2/20 0.61
▸ HDAC11 Q96DB2 2/20 0.61
▸ HDAC6 Q9UBN7 2/20 0.61
▸ HDAC9 Q9UKV0 2/20 0.61
▸ HDAC5 Q9UQL6 2/20 0.61
▸ NPC1 O15118 1/20 0.55
▸ CASP3 P42574 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ SENP8 Q96LD8 1/20 0.55
▸ SENP7 Q9BQF6 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8611727 0.94 TDP1 (0.64) TDP1L3MBTL1MAPTLMNAHDAC1
SCHEMBL8608674 0.86 TDP1 (0.57) TDP1L3MBTL1MAPTLMNAHDAC1
SCHEMBL7068671 0.84 TDP1 (0.95) TDP1L3MBTL1MAPTLMNAHDAC1
SCHEMBL7546343 0.83 TDP1 (0.70) TDP1L3MBTL1MAPTLMNAHDAC1
SCHEMBL8519287 0.82 TDP1 (1.00) TDP1L3MBTL1MAPTLMNAHDAC1
SCHEMBL27516050 0.82 TDP1 (1.00) TDP1L3MBTL1MAPTLMNAHDAC1
SCHEMBL9057671 0.82 TDP1 (1.00) TDP1L3MBTL1MAPTLMNAHDAC1
SCHEMBL7551879 0.81 TDP1 (0.74) TDP1L3MBTL1MAPTLMNAHDAC1
SCHEMBL28052282 0.81 TDP1 (0.74) TDP1L3MBTL1MAPTLMNAHDAC1
SCHEMBL12854830 0.81 MAPT (0.68) TDP1L3MBTL1MAPTLMNAHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0457195-B1 Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1998-04-15 — — EP disclosed
US-5656604-A HYPOTENSIVE AGENT; ENDOTHELIN ANTAGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-12 — — US disclosed
US-5430022-A Endothelin antagonists; hypotensive agents; treatment for angina pectoris, brain disorders, asthma, renal failure FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-07-04 — — US disclosed
US-5284828-A Hypotensive agents FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 1994-02-08 — — US disclosed
EP-0457195-A2 Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-11-21 — — EP disclosed
Send feedback